Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the study record remains unavailable on the page.
    Difference
    0.2%
    Check dated 2026-11-02T15:42:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:29:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:09:59.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:22.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates the record is temporarily unavailable.
    Difference
    18%
    Check dated 2026-09-21T20:28:49.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a new site revision label: v3.6.6, replacing the previous v3.6.5. This reflects a software update and does not modify the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:02.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.